Evidence map›Paper›PMID 28191473›Full record

ArticleJournal of immunology research2017

Evolution of the Immune Response against Recombinant Proteins (TcpA, TcpB, and FlaA) as a Candidate Subunit Cholera Vaccine.

Neda Molaee, Ghasem Mosayebi, Alireza Amozande-Nobaveh, Mohammad Reza Soleyman, Hamid Abtahi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A polyvalent multiepitope protein cross-protects againstProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  2. Recombinant Globular Domain of TcpA Pilin fromLife (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Antigenic and immunogenic evaluation ofIranian journal of basic medical sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Neda MolaeeDepartment of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Ghasem MosayebiDepartment of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.ORCID 0000-0003-3877-0783
Alireza Amozande-NobavehDepartment of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Mohammad Reza SoleymanDepartment of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Hamid AbtahiMolecular and Medicine Research Center, Department of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.ORCID 0000-0003-3270-4304

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntibodies, BacterialCholeraCholera VaccinesDisease Models, AnimalFimbriae ProteinsFlagellaFlagellinHumansImmunity, HumoralImmunoglobulin GInterferon-gammaInterleukin-5MiceRecombinant ProteinsSpleenAntibodies, BacterialCholera VaccinesFimbriae ProteinsflaA protein, bacteriaFlagellinImmunoglobulin GInterferon-gammaInterleukin-5Recombinant ProteinsTcpA protein, Vibrio choleraeTcpB protein, Vibrio choleraeVaccines, Subunit

Identifiers

PMID28191473
PMCPMC5278207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.